MM+M will host its fifth annual Media Summit on Tuesday, October 29 in New York City. This year, MM+M’s journalists and ...
The mandates will put extra strain on an already-stressed workforce, potentially making it harder for enrollees to get basic ...
WPP has started a potential sales process for its PR division, which includes communications agency Burson, according to ...
Small biotechs weigh options under tariff threats; Lilly’s new GLP-1 drug appeals to patients in maintenance phase; Meat sales go up in the U.S.
Without the backstop of mandates, vaccine products face a steep uphill climb to penetrate clinical conversations. Here's what ...
In this conversation, we sit down with Assembled Intelligence’s Chuck Hemann and InVibe’s Christopher Farina to discuss what ...
The Montana state Department of Public Health and Human Services postponed adding doula services to its Medicaid program in ...
Among critical-care doctors, prolonged symptoms like his are known as “post-intensive care syndrome,” or PICS. The fallout ...
In an Untitled Letter, regulators said Facebook promotions for Pfizer’s lymphoma therapy overstated its approved use and ...
The failure of a hospital chain that provided its own malpractice insurance threatens to leave injured patients with no ...
After a month without publicly releasing an Untitled Letter, the FDA issued complaints to Amneal Pharmaceuticals and BioCorRx ...
Ro is expanding its weight-loss offering with the addition of Eli Lilly’s newly approved oral GLP-1, Foundayo (orforglipron), giving patients a second daily pill alternative to injectable therapies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results